Skip to main content
OpenTrials

Clinical trial condition

Reoviridae Infections

Explore clinical trials studying Reoviridae Infections. Study availability and eligibility vary by location and protocol.

90 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Reoviridae Infections trial results

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

NCT00334607

Conditions
Diarrhea, Infections, Infections, Rotavirus, +7 more
Locations
  • GSK Investigational Site Benton, Arkansas, United States
  • GSK Investigational Site Cabot, Arkansas, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
View all 42 locations
View Trial Details
Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

NCT00139347

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations
  • GSK Investigational Site Colonia Caroya, Córdoba Province, Argentina
  • GSK Investigational Site Córdoba, Córdoba Province, Argentina
  • GSK Investigational Site Río Cuarto, Córdoba Province, Argentina
  • GSK Investigational Site Mendoza, Mendoza Province, Argentina
View all 17 locations
View Trial Details
Completed

Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

NCT00134732

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations
  • GSK Investigational Site Bucheon-si, South Korea
  • GSK Investigational Site Daejeon, South Korea
  • GSK Investigational Site Jeonju, South Korea
  • GSK Investigational Site Seoul, South Korea
View Trial Details
Completed

Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

NCT00137930

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations
  • GSK Investigational Site Lahti, Finland
  • GSK Investigational Site Oulu, Finland
  • GSK Investigational Site Pori, Finland
  • GSK Investigational Site Tampere, Finland
View Trial Details

Related conditions